CBI arrests Joints Drug Controller of CDSCO, aide in bribery case

by IANS |

New Delhi, June 21 (IANS) The Central Bureau of Investigation (CBI) has said that they have apprehended a Joint Drug Controller (JDC) of Central Drugs Standard Control Organisation (CDSCO) and the Director of a private company for allegedly demanding bribe to waive the Phase-3 trial of "Insulin Aspart Injection".

The accused JDC identified as E. Eswara Reddy posted with CDSCO headquarters, New Delhi, while his aide was identified as Dinesh Dua, the Director of Delhi-based Synergy Network India Private Limited.

A senior CBI official said that a case was lodged against Reddy, Dua and others which includes Guljit Sethi, the Director of Bioinnovat Research Service Private Limited; L. Praveen Kumar, the Associate Voice President and Head of National Regulatory Affairs of Biocon Biologics Limited; Animesh Kumar, the Assistant Drug Inspector of CDSCO and others.

"It was alleged that Reddy was trying to exert undue influence on officers of CDSCO to waive the Phase-3 trial of "Insulin Aspart Injection". The accused agreed to pay bribe amount of Rs 9 lakh to Reddy for favourably processing the said three files related to Banglore-based Biocon Biologics Limited and also for favourably recommending the file of "Insulin Aspart injection" to the Subject Expert Committee meeting.

The CBI laid a trap wherein Reddy was caught while accepting a bribe of Rs 4 lakh from Dua.

The CBI also conducted searches at 11 locations in Delhi, Noida, Gurugram, Patna, Bengaluru which led to the recovery of incriminating documents.

Meanwhile, the Biocon Biologics issued a ststement saying their Aspart was approved in Europe and many other countries.

"We deny few allegations reported in India. All our product approvals are legitimate and backed by science and clinical data. Our Aspart is approved in Europe and many other countries. We follow due regulatory process for all our product approvals by DCGI. The entire application process in India is online and all meeting minutes are in public domain. We are co-operating with the investigation agency," said Biocon Biologics in a press release.

Further investigation in the matter is underway.

Latest News
Teenager shot at in Delhi, police launches probe Fri, Jun 09, 2023, 04:48 PM
Indian-American White House Covid response coordinator to step down Fri, Jun 09, 2023, 04:47 PM
How human immune system detects Covid Fri, Jun 09, 2023, 04:46 PM
Sri Lanka leave out Mathews, include Pathirana for ODI World Cup Qualifiers Fri, Jun 09, 2023, 04:45 PM
9 in 10 B2B marketing leaders in India to boost use of generative AI: Report Fri, Jun 09, 2023, 04:44 PM
With over 4 lakh styles, menswear category on Myntra woos customers during EORS 18 Fri, Jun 09, 2023, 04:43 PM
Cyberabad police arrests 10 people for selling spurious seeds Fri, Jun 09, 2023, 04:41 PM
Punjab to construct high-security digital jail near Ludhiana: CM Mann Fri, Jun 09, 2023, 04:40 PM
Odisha CM Patnaik drops Higher Education Minister Rohit Pujari from ministry Fri, Jun 09, 2023, 03:52 PM
Japan passes contentious bill to revise immigration, refugee law Fri, Jun 09, 2023, 03:40 PM
Wild poliovirus detected in environmental sample in Karachi Fri, Jun 09, 2023, 03:30 PM
Pet cats killing 323 mn native Australian animals annually: Report Fri, Jun 09, 2023, 03:12 PM
Mallikarjun Kharge, Rahul to attend Oppn meeting in Patna on June 23 Fri, Jun 09, 2023, 02:38 PM
Soaring air fares play spoiler for family holidays Fri, Jun 09, 2023, 02:32 PM
Ashes 2023: England have slightly different plans for Smith this time, says Ollie Pope Fri, Jun 09, 2023, 02:19 PM